{
    "@context": "https://schema.org",
    "@type": "Article",
    "headline": "PTAB Institutes Two IPRs on Tocilizumab Patents",
    "url": "https://www.lexblog.com/2022/01/10/ptab-institutes-two-iprs-on-tocilizumab-patents/",
    "identifier": {
        "@type": "PropertyValue",
        "name": "LexBlog Library record",
        "value": "LEX-WK-76EWQ426",
        "url": "https://www.lexblog.com/lib/76EWQ426/"
    },
    "datePublished": "2022-01-10T14:54:27-05:00",
    "dateModified": "2022-01-10T14:54:28-05:00",
    "author": {
        "@type": "Person",
        "name": "Big Molecule Watch"
    },
    "sourceOrganization": {
        "@type": "Organization",
        "name": "Goodwin Procter"
    },
    "organizationScope": "at-publication",
    "isPartOf": "Big Molecule Watch",
    "about": "Intellectual Property",
    "sourceUrl": "https://www.bigmoleculewatch.com/2022/01/10/ptab-institutes-two-iprs-on-tocilizumab-patents/",
    "sourceStability": "may-move"
}